West Pharmaceutical Services Inc (WST)
390.20
+14.85
(+3.96%)
USD |
NYSE |
Apr 23, 16:00
390.98
+0.78
(+0.20%)
After-Hours: 20:00
West Pharmaceutical Services Cash from Investing (TTM): -368.70M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -368.70M |
| September 30, 2023 | -354.70M |
| June 30, 2023 | -318.10M |
| March 31, 2023 | -302.00M |
| December 31, 2022 | -288.20M |
| September 30, 2022 | -270.80M |
| June 30, 2022 | -277.00M |
| March 31, 2022 | -266.90M |
| December 31, 2021 | -253.10M |
| September 30, 2021 | -233.30M |
| June 30, 2021 | -217.10M |
| March 31, 2021 | -202.10M |
| December 31, 2020 | -179.50M |
| September 30, 2020 | -242.50M |
| June 30, 2020 | -225.00M |
| March 31, 2020 | -231.20M |
| December 31, 2019 | -228.00M |
| September 30, 2019 | -136.00M |
| June 30, 2019 | -130.90M |
| March 31, 2019 | -100.80M |
| December 31, 2018 | -100.80M |
| September 30, 2018 | -101.60M |
| June 30, 2018 | -109.10M |
| March 31, 2018 | -127.60M |
| December 31, 2017 | -133.60M |
| Date | Value |
|---|---|
| September 30, 2017 | -150.90M |
| June 30, 2017 | -164.80M |
| March 31, 2017 | -171.90M |
| December 31, 2016 | -175.80M |
| September 30, 2016 | -173.00M |
| June 30, 2016 | -154.60M |
| March 31, 2016 | -137.50M |
| December 31, 2015 | -129.50M |
| September 30, 2015 | -111.90M |
| June 30, 2015 | -103.10M |
| March 31, 2015 | -99.00M |
| December 31, 2014 | -104.00M |
| September 30, 2014 | -116.60M |
| June 30, 2014 | -125.00M |
| March 31, 2014 | -127.80M |
| December 31, 2013 | -149.90M |
| September 30, 2013 | -133.70M |
| June 30, 2013 | -130.10M |
| March 31, 2013 | -141.80M |
| December 31, 2012 | -116.00M |
| September 30, 2012 | -129.60M |
| June 30, 2012 | -136.10M |
| March 31, 2012 | -123.30M |
| December 31, 2011 | -120.50M |
| September 30, 2011 | -102.80M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-368.70M
Minimum
Dec 2023
-130.90M
Maximum
Jun 2019
-248.69M
Average
-242.50M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
| Becton Dickinson & Co | -658.00M |
| Abbott Laboratories | -3.133B |
| Masimo Corp | -81.20M |
| Merit Medical Systems Inc | -175.35M |
| Insulet Corp | -119.40M |